Emerging Infections Program

Forms and Documents

Document Name	Status
2013 Legionellosis ABCs Case Report Form	Modified
ABCs Neonatal Infection Expanded Tracking Form Form	Modified
Invasive Methicillin - Resistant - Staphylococcus aureus ABCs Case Report Form Form	Modified
ABCs Case Report Form Form	Modified
Attachment 1_2013_OMB ABCs forms FINAL_09162013.doc Justification for No Material/Nonsubstantive Change	2013-09-17

IC Document Collections

IC ID	Document Title	Status
207663	Yersinia Other-WORD	Modified
207662	Vibrio Other-WORD	Modified
207661	Shigella Other-WORD	Modified
207660	Shiga toxin producing E. coli Other-WORD	Modified
207659	Salmonella Other-WORD	Modified
207658	Listeria monocytogenes Other-WORD	Modified
207657	Cyclospora Other-WORD	Modified
207656	Cryptosporidium Other-WORD	Modified
207655	Campylobacter Other-WORD	Modified
207654	Consent Form Other-WORD	Modified
207653	Influenza Hospitalization Surveillance Project Vaccination Telephone Survey Other-WORD	Modified
207652	Hemolytic Uremic Syndrome (HUS) Other-WORD	Modified
207651	2011-12 FluSurv-NET Influenza Hospitalization Surveilance Project Case Report Form Other-WORD	Modified
207650	2013 Legionellosis ABCs Case Report Form	Modified
207649	ABCs Neonatal Infection Expanded Tracking Form Form	Modified
207648	ABCs Invasive Pneumococcal Disease in Children Other-WORD	Modified
207647	Invasive Methicillin - Resistant - Staphylococcus aureus ABCs Case Report Form Form	Modified
207646	ABCs Case Report Form Form	Modified

ICR Details

OMB Control No: 0920-0978	ICR Reference No: 201309-0920-007
Status: Historical Active	Previous ICR Reference No: 201307-0920-003
Agency/Subagency: HHS/CDC	Agency Tracking No: 20546
Title: Emerging Infections Program
Type of Information Collection: No material or nonsubstantive change to a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 09/26/2013
	Date Received in OIRA: 09/19/2013
Terms of Clearance: Previous terms continue: Approved consistent with the understanding that this consolidation will result in the modification and/or discontinuation of related CDC ICRs.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	08/31/2016	08/31/2016	08/31/2016
Responses	41,200	0	41,200
Time Burden (Hours)	12,319	0	12,319
Cost Burden (Dollars)	0	0	0

---

Abstract: CDC is requesting changes to this Information Collection. The Emerging Infections Programs (EIPs) are population-based centers of excellence established through a network of state health departments collaborating with academic institutions; local health departments; public health and clinical laboratories; infection control professionals; and healthcare providers. EIPs assist in local, state, and national efforts to prevent, control, and monitor the public health impact of infectious diseases. Activities of the EIPs fall into the following general categories: (1) active surveillance; (2) applied public health epidemiologic and laboratory activities; (3) implementation and evaluation of pilot prevention/intervention projects; and (4) flexible response to public health emergencies. Activities of the EIPs are designed to: (1) address issues that the EIP network is particularly suited to investigate; (2) maintain sufficient flexibility for emergency response and new problems as they arise; (3) develop and evaluate public health interventions to inform public health policy and treatment guidelines; (4) incorporate training as a key function; and (5) prioritize projects that lead directly to the prevention of disease.

---

Authorizing Statute(s): US Code: 42 USC 301 Name of Law: Public Health Service Act
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments

Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 18

IC Title	Form No.	Form Name
ABCs Case Report Form	none	Case Report
Invasive Methicillin - Resistant - Staphylococcus aureus ABCs Case Report Form	none	Invasive MRSA
ABCs Invasive Pneumococcal Disease in Children
ABCs Neonatal Infection Expanded Tracking Form	none	Neonatal Infection
2013 Legionellosis ABCs Case Report	none	Legionellosis
2011-12 FluSurv-NET Influenza Hospitalization Surveilance Project Case Report Form
Hemolytic Uremic Syndrome (HUS)
Influenza Hospitalization Surveillance Project Vaccination Telephone Survey
Consent Form
Campylobacter
Cryptosporidium
Cyclospora
Listeria monocytogenes
Salmonella
Shiga toxin producing E. coli
Shigella
Vibrio
Yersinia

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	41,200	41,200	0	0	0	0
Annual Time Burden (Hours)	12,319	12,319	0	0	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $6,872,123

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 09/18/2013

---